A pharmacokinetic drug interaction study between nebivolol and paroxetine in healthy volunteers

Author:

Briciu C.1,Neag M.2,Muntean D.3,Vlase L.3,Bocsan C.2,Buzoianu A.2,Gheldiu A.-M.3,Achim M.3,Popa A.1

Affiliation:

1. Faculty of Pharmacy; Department of Clinical Pharmacy; University of Medicine and Pharmacy “Iuliu Hatieganu”; Cluj-Napoca Romania

2. Faculty of Medicine; Department of Pharmacology, Toxicology and Clinical Pharmacology; University of Medicine and Pharmacy “Iuliu Hatieganu”; Cluj-Napoca Romania

3. Faculty of Pharmacy; Department of Pharmaceutical Technology and Biopharmaceutics; University of Medicine and Pharmacy “Iuliu Hatieganu”; Cluj-Napoca Romania

Funder

CNCS Romania - project

Sectoral Operational Programme for Human Resources Development

European Social Fund

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference34 articles.

1. β-blockers in the management of hypertension: focus on nebivolol;Wojciechowski;Expert Rev Cardiovasc Ther,2008

2. A review of the safety and efficacy of nebivolol in the mildly hypertensive patient;Cockcroft;J Vasc Health Risk Manag,2007

3. Nebivolol: a review of its use in the management of hypertension and chronic heart failure;Moen;Drugs,2006

4. Nebivolol: a new antihypertensive agent;Gray;Am J Health Syst Pharm,2008

5. Nebivolol: a review of its clinical and pharmacological characteristics;Gielen;Int J Clin Pharmacol Ther,2006

Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3